Current Awareness
Current awareness: Pharmacoepidemiology and drug safety
First published: 21 February 2005
Abstract
In order to keep subscribers up-to-date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of pharmacoepidemiology and drug safety. Each bibliography is divided into 20 sections: 1 Books, Reviews & Symposia; 2 General; 3 Anti-infective Agents; 4 Cardiovascular System Agents; 5 CNS Depressive Agents; 6 Non-steroidal Anti-inflammatory Agents; 7 CNS Agents; 8 Anti-neoplastic Agents; 9 Haematological Agents; 10 Neuroregulator-Blocking Agents; 11 Dermatological Agents; 12 Immunosuppressive Agents; 13 Autonomic Agents; 14 Respiratory System Agents; 15 Neuromuscular Agents; 16 Reproductive System Agents; 17 Gastrointestinal System Agents; 18 Anti-inflammatory Agents - Steroidal; 19 Teratogens/fetal exposure; 20 Others. Within each section, articles are listed in alphabetical order with respect to author. If, in the preceding period, no publications are located relevant to any one of these headings, that section will be omitted.
References
- 1. Books, Reviews & Symposia
- Special issue: 20th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Bordeaux, France, 22-25 August 2004 (Abstracts). Pharmacoepidemiol Drug Saf (2004); 13:
- Special issue: Benefit/Risk of New Drugs for Rheumatoid Arthritis. Clin Exp Rheumatol (2004); 22:
- Special issue: Management of the Digestive Risk in Patients Treated with NSAIDS (Articles in French). Gastroenterol Clin Biol (2004); 28:
- Albrecht CA. Proarrhythmia with non-antiarrhythmics - A review. Cardiology (2004); 102: 122.
- Dancer SJ. How antibiotics can make us sick: The less obvious adverse effects of antimicrobial chemotherapy (Review). Lancet Infect Dis (2004); 4: 611.
- Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity (Review). Drug Saf (2004); 27: 799.
- De With K, Schroder H, Meyer E, Nink K, Hoffmann S, Steib-Bauert M, Kammerer R, Ruess S, Daschner FD, Kern WV. Antibiotic use in Germany and Europe (Review) (German, English Abstract). Dtsch Med Wochenschr (2004); 129: 1987.
- Dimopoulos MA, Eleutherakis-Papaiakovou V. Adverse effects of thalidomide administration in patients with neoplastic diseases (Review). Am J Med (2004); 117: 508.
- Edwards JE, McQuay HJ, Moore RA. Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials. Pain (2004); 111: 286.
- Gomes MPV, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy - A clinical review. Arch Intern Med (2004); 164: 1965.
- Guru V, Fremes SE. The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy. Clin Nephrol (2004); 62: 77.
- Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and management (Review). Drugs (2004); 64: 2291.
- Hedner T, Samulesson O, Wahrborg P, Wadenvik H, Ung KA, Ekbom A. Nabumetone - Therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis (Review). Drugs (2004); 64: 2315.
- Hooper L, Brown TJ, Elliott RA, Payne K, Roberts C, Symmons D. The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced lay non-steroidal anti-inflammatory drugs: Systematic review. Br Med J (2004); 329: 948.
- Huang DB, Wu JJ, Tyring SK. A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines. J Infect (2004); 49: 179.
- Kennedy RC, Byers VS, Marchalonis JJ. Measles virus infection and vaccination: Potential role in chronic illness and associated adverse events. Crit Rev Immunol (2004); 24: 129.
- Kimmey MB. Cardioprotective effects and gastrointestinal risks of aspirin: Maintaining the delicate balance. Am J Med (2004); 117: 72S.
- Mannel M. Drug interactions with St John's wort - Mechanisms and clinical implications (Review). Drug Saf (2004); 27: 773.
- O'Hagan DT, Rappuoli R. The safety of vaccines. Drug Discov Today (2004); 9: 846.
- Ocean AJ, Vahdat LT. Chemotherapy-induced peripheral neuropathy: Pathogenesis and emerging therapies (Review). Support Care Cancer (2004); 12: 619.
- Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonucelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F. Levodopa in the treatment of Parkinson's disease: Current controversies (Review). Mov Disord (2004); 19: 997.
- Olsen NJ. Drug-induced autoimmunity. Best Pract Res Clin Rheumatol (2004); 18: 677.
- Sanchez AR, Rogers RS, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity (Review). Int J Dermatol (2004); 43: 709.
- Stevinson C, Ernst E. Can St. John's wort trigger psychoses?. Int J Clin Pharmacol Ther (2004); 42: 473.
- Van Schayck CP, Donnell D. The efficacy and safety of QVAR (hydrofluoroalkanebeclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children (Review). Int J Clin Pract (2004); 58: 786.
- Veljkovic V, Prljic J, Veljkovic T. Safety and ethical consideration of AIDS vaccine. Int Rev Immunol (2004); 23: 465.
- 2. General
- Aronson JK. Classifying drug interactions (Editorial). Br J Clin Pharmacol (2004); 58: 343.
- Bucca C. Take the side-effects of drugs into account. Lancet (2004); 364: 1285.
- Caamano F, Tome-Otero M, Takkouche B, Gestal-Otero JJ. Factors associated with the decision of Spanish pharmacists to prescribe medicines and to recommend the visit to a doctor. Pharmacoepidemiol Drug Saf (2004); 13: 817.
- Camus P, Bonniaud P, Fanton A, Camus C, Baudaun N, Foucher P. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med (2004); 25: 479.
- Etminan M, Carleton B, Rochon PA. Quantifying adverse drug events - Are systematic reviews the answer?. Drug Saf (2004); 27: 757.
- Forster AJ, Van Walraven C. Adverse events: Past and future (Response). Can Med Assoc J (2004); 171: 550.
- Harrold LR, Andrade SE, Eisner M, Buist AS, Go A, Vollmer WM, Chan KA, Frazier EA, Weller PF, Wechsler ME, Davis KJ, Platt R. Identification of patients with Churg-Strauss syndrome (CSS) using automated data. Pharmacoepidemiol Drug Saf (2004); 13: 661.
- Hauben M. Early postmarketing drug safety surveillance: Data mining points to consider. Ann Pharmacother (2004); 38: 1625.
- Johnson N, Roy MT. Adverse events: Past and future (Letter). Can Med Assoc J (2004); 171: 549.
- Lankinen KS, Levola T, Marttinen K, Puumalainen I, Helin-Salmivaara A. Industry guidelines, laws and regulations ignored: Quality of drug advertising in medical journals. Pharmacoepidemiol Drug Saf (2004); 13: 789.
- Mansfield PR, Henry D. Misleading drug promotion - No sign of improvements (Editorial). Pharmacoepidemiol Drug Saf (2004); 13: 797.
- Motl S, Timpe E, Eichner S. Proposal to improve MedWatch: Decentralized, regional surveillance of adverse drug reactions (Commentary). Am J Health Syst Pharm (2004); 61: 1840.
- Muldoon C. Pharmaceutical advertising: Fact or fiction? (Editorial). Pharmacoepidemiol Drug Saf (2004); 13: 801.
- Ruedy J, Ogilvie RI. Adverse events: Past and future (Letter). Can Med Assoc J (2004); 171: 549.
- Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC. Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf (2004); 27: 819.
- Urquhart G, Sinclair HK, Hannaford PC. The use of non-prescription medicines by general practitioner attendees. Pharmacoepidemiol Drug Saf (2004); 13: 773.
- Vedsted P, Sorensen HT, Mortensen JT. Drug prescription for adult frequent attenders in Danish general practice: A population-based study. Pharmacoepidemiol Drug Saf (2004); 13: 717.
- Verma A, Lilienfeld DE. The need for a population-based surveillance system for liver disease in the United States (ISPE Commentary). Pharmacoepidemiol Drug Saf (2004); 13: 821.
- Vlahovic-Palcevski V, Wettermark B, Prpic I, Bergman U. Attitudes to feedback with drug utilisation 90% (DU90%) profiles among prescribers in Rijeka, Croatia (Letter). Pharmacoepidemiol Drug Saf (2004); 13: 725.
- 3. Anti-infective Agents
- Adam I, Elbashir MI. Extrapyramidal syndrome after treatment of falciparum malaria with sulphadoxine-pyrimethamine. Saudi Med J (2004); 25: 1303.
- AMD3100 HIV Study Grp. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol (2004); 37: 1253.
- Amin AA, Hughes DA, Marsh V, Abuya TO, Kokwaro GO, Winstanley PA, Ochola SA, Snow RW. The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Trop Med Int Health (2004); 9: 967.
- Andreae MC, Freed GL, Katz SL. Safety concerns regarding combination vaccines: The experience in Japan. Vaccine (2004); 22: 3911.
- Arness MK, Eckart RE, Love SS, Atwood JE, Wells TS, Engler RJM, Collins LC, Ludwig SL, Riddle JR, Grabenstein JD, Tomberg DN. Myopericarditis following smallpox vaccination. Am J Epidemiol (2004); 160: 642.
- Ayudhya DPN, Thanompuangseree N, Tansuphaswadikul S. Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. Clin Pharmacokinet (2004); 43: 725.
- Biselli M, Lorenzini S, Gramenzi A, Andreone P, Bernardi M, Rossi C, Grazi GL. Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon α-2b and ribavirin (Letter). Transplantation (2004); 78: 953.
- Boucher HW, Groll AH, Chiou CC, Walsh TJ. Newer systemic antifungal agents - Pharmacokinetics, safety and efficacy. Drugs (2004); 64: 1997.
- Chippaux JP, Garba A, Ethevenaux C, Campagne G, De Chabalier F, Djibo S, Nicolas P, Ali H, Charrondiere M, Ryall R, Bybel M, Schuchat A. Immunogenicity, safety, and memory of different schedules of Neisseria meningitidis A/C-diphtheria toxoid conjugate vaccine in infants in Niger. Vaccine (2004); 22: 3303.
- Colebunders R, De Schacht C, Vanwolleghem T, Callens S. Lopinavir/ritonavir - And indinavir-induced thrombocytopenia in a patient with HIV infection (Letter). Int J Infect Dis (2004); 8: 315.
- Criado PR, Ramos RD, Vasconcellos C, Criado RFJ, Valente NYS. Two case reports of cutaneous adverse reactions following hepatitis B vaccine: Lichen planus and granuloma annulare. J Eur Acad Dermatol Venereol (2004); 18: 603.
- Del Giudice P, Vandenbos F, Perrin C, Bernard E, Marq L, Dellamonica P. Sweet's syndrome following abacavir therapy (Letter). J Am Acad Dermatol (2004); 51: 474.
- Dolan CK, Hall MA, Blazes DL, Norwood CW. Pseudoporphyria as a result of voriconazole use: A case report. Int J Dermatol (2004); 43: 768.
- Geier MR, Geier DA. Mercury in vaccines and potential conflicts of interest (Letter). Lancet (2004); 364: 1217.
- Gendel I, Azzam ZS, Braun E, Levy Y, Krivoy N. Antibiotic utilization prevalence: Prospective comparison between two medical departments in a tertiary care university hospital. Pharmacoepidemiol Drug Saf (2004); 13: 735.
- Gillman PK. Comment on: Serotonin syndrome due to co-administration of linezolid and venlafaxine (Letter). J Antimicrob Chemother (2004); 54: 844.
- Gilmore ES, Friedman JS, Morrell DS. Extensive fixed drug eruption secondary to vancomycin. Pediatr Dermatol (2004); 21: 600.
- Hak E, Bonten MJM. MMR vaccination and febrile seizures (Letter). JAMA (2004); 292: 2083.
- Iskander JK, Miller ER, Chen RT. The role of the Vaccine Adverse Event Reporting System (VAERS) in monitoring vaccine safety. Pediatr Ann (2004); 33: 599.
- Kaygusuz I, Kaygusuz TO, Ozturk A, Kilic SS, Karlidag T, Keles E, Yalcin S. Effects of interferon-alpha2b on hearing. Int J Audiol (2004); 43: 438.
- Kirian MA, Higginson RT, Fulco PP. Acute onset of pancreatitis with concomitant use of tenofovir and didanosine (Case Report). Ann Pharmacother (2004); 38: 1660.
- Le Guyader N, Auvrignon A, Vu-Thien H, Portier E, Tabone MD, Leverger G. Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children. Support Care Cancer (2004); 12: 720.
- Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM. Safety and immunogenicity of Haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population. J Am Geriatr Soc (2004); 52: 1883.
- McMurray R, Cheater FM, Weighall A, Nelson C, Schweiger M, Mukherjee S. Managing controversy through consultation: A qualitative study of communication and trust around MMR vaccination decisions. Br J Gen Pract (2004); 54: 520.
- Molloy ES, Powell FC, Doran MF, Ryan JG, Mulligan NJ, McCarthy C, Keogan MT, McCarthy GM. An unusual case of Behcet's syndrome: Triggered by typhoid vaccination? (Case Report). Clin Exp Rheumatol (2004); 22: S71.
- Montpetit MC, Shammo JL, Loew J, Dunlap S, Pamboukian SV, Heroux A. Sideroblastic anemia due to linezolid in a patient with a left ventricular assist devicer. J Heart Lung Transplant (2004); 23: 1119.
- Nacarkucuk E, Saglam H, Okan M. Meropenem decreases serum level of valproic acid. Pediatr Neurol (2004); 31: 232.
- Pichichero ME, Treanor J. Mercury in vaccines and potential conflicts of interest (Reply). Lancet (2004); 364: 1217.
- Schneider V, Suissa S. Antibiotic use and the development of Crohn's disease: Methodological issues (Letter). Gut (2004); 53: 1544.
- Seckin D, Durusoy C, Sahin S. Concomitant vitiligo and psoriasis in a patient treated with interferon α-2a for chronic hepatitis B infection. Pediatr Dermatol (2004); 21: 577.
- Senneville E, Legout L, Valette M, Yazdanpanah Y, Giraud F, Beltrand E, Obert G, Dubreuil L, Migaud H, Mouton Y. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: A case-control study. J Antimicrob Chemother (2004); 54: 798.
- Skoog SM, Smyrk TC, Talwalkar JA. Cephalexin-induced cholestatic hepatitis (Letter). J Clin Gastroenterol (2004); 38: 833.
- Spellberg B, Yoo T, Bayer AS. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. J Antimicrob Chemother (2004); 54: 832.
- Sulsky SI, Grabenstein JD, Delbos RG. Disability among US army personnel vaccinated against anthrax. J Occup Environ Med (2004); 46: 1065.
- Tornero P, De Barrio M, Baeza ML, Herrero T. Cross-reactivity among p-amino group compounds in sulfonamide fixed drug eruption: Diagnostic value of patch testing. Contact Dermatitis (2004); 51: 57.
- Tsutsumi Y, Ehira N, Kanamori H, Yamato H, Obara S, Tanaka J, Asaka M, Imamura M, Masauzi N. Pancreatitis complications in a patient with myelodysplastic syndrome, who was treated with fluconazole (Letter). Int J Clin Pract (2004); 58: 811.
- Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): Data collection performance and methodological approach. Br J Clin Pharmacol (2004); 58: 419.
- Vestergaard M, Madsen KM, Olsen J, Hviid A, Wohlfahrt J, Melbye M, Thorsen P, Schendel D. MMR vaccination and febrile seizures (Reply). JAMA (2004); 292: 2083.
- Wise RP, Iskander J, Pratt RD, Campbell S, Ball R, Pless RP, Braun MM. Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA (2004); 292: 1702.
- 4. Cardiovascular System Agents
- Agarwal R. Statin induced proteinuria: Renal injury or renoprotection?. J Am Soc Nephrol (2004); 15: 2502.
- Bas M, Kojda G, Bier H, Hoffmann TK. ACE inhibitor-induced angioedema in the head and neck region. A matter of time? (German, English Abstract). HNO (2004); 52: 886.
- Bleumink GS, Deinum J, Mosterd A, Witteman JCM, Hofman A, Stricker BHC. Antihypertensive treatment is associated with improved left ventricular geometry: The Rotterdam Study. Pharmacoepidemiol Drug Saf (2004); 13: 703.
- Da Silva RMG. Captopril-induced bilateral parotid and submandibular sialadenitis. Eur J Clin Pharmacol (2004); 60: 449.
- Davidson MH, Ballantyne CM, Kerzner B, Melani L, Sager PT, Lipka L, Strony J, Suresh R, Veltri E. Efficacy and safety of ezetimibe coadministered with statins: Randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia. Int J Clin Pract (2004); 58: 746.
- Eriksson BI, Dahl OE, Ahnfelt L, Kalebo P, Stangier J, Nehmiz G, Hermansson K, Kohlbrenner V. Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. J Thromb Haemost (2004); 2: 1573.
- Hall MA, Annas A, Nyman K, Talme T, Emtestam L. Basalioma after amiodarone therapy - Not only in Britain (Letter). Br J Dermatol (2004); 151: 932.
- Hamacher T, Schinzel M, Scholzel-Klatt A, Neff HM, Maier H, Schlaffer G, Beausencourt E, Jutte M, Scholz R, Lorger C, Stewart WC. Short term efficacy and safety in glaucoma patients changed to the latanoprost 0.005%/timolol maleate 0.5% fixed combination from monotherapies and adjunctive therapies. Br J Ophthalmol (2004); 88: 1295.
- Haverkamp F, Wuensch S, Fuchs M, Stewart WC. Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments. Eur J Ophthalmol (2004); 14: 407.
- Kanbay M, Korkmaz M, Yilmaz U, Gur G, Boyacioglu S. Acute pancreatitis due to ramipril therapy. Postgrad Med J (2004); 80: 617.
- Labs KH, Degischer S, Gamba G, Jaeger KA. Effectiveness and safety of calcium dobesilate in treating chronic venous insufficiency: Randomized, double-blind, placebo-controlled trial. Phlebology (2004); 19: 123.
- McCollum DL, Greene JL, McGuire DK. Severe sinus bradycardia after initiation of bupropion therapy: A probable drug-drug interaction with metoprolol. Cardiovasc Drugs Ther (2004); 18: 329.
- Meyer T, Boven KH, Gunther E, Fejtl M. Micro-electrode arrays in cardiac safety pharmacology - A novel tool to study QT interval prolongation. Drug Saf (2004); 27: 763.
- Mickley H, Poulsen TS. Use of sildenafil is safe in men with congestive heart failure (Letter). Arch Intern Med (2004); 164: 2068.
- Mikhail N. Efficacy and safety of sildenafil in patients with congestive heart failure (Letter). Arch Intern Med (2004); 164: 2067.
- Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: Results of a randomized trial. Clin Ther (2004); 26: 1419.
- Palomar R, Morales P, De Castro SS, Tasis A, Rodrigo E, Ruiz JC, Fernandez-Fresnedo G, De Francisco ALM, Arias M. Pleural effusion secondary to minoxidil in a peritoneal dialysis patient (Letter). Nephrol Dial Transplant (2004); 19: 2688.
- Rao JG, Campbell ME, Krol A. The harlequin color change and association with prostaglandin E1. Pediatr Dermatol (2004); 21: 573.
- Reyderman L, Kosoglou T, Statkevich P, Pember L, Boutros T, Maxwell SE, Affrime M, Batra V. Assessment of a multiple-dose drug interaction between ezetimibe, a novel selective cholesterol absorption inhibitor and gemfibrozil. Int J Clin Pharmacol Ther (2004); 42: 512.
- Rinard J, Rodriguez S, Ormseth E. Quinidine-induced gastric ulcer. Gastrointest Endosc (2004); 60: 481.
- Seino Y, Yamauchi M, Hirai C, Okumura A, Kondo K, Yamamoto M, Okazaki Y. A case of fulminant type 1 diabetes associated with mexiletine hypersensitivity syndrome (Letter). Diabetic Med (2004); 21: 1156.
- Serebruany VL, Midei MG, Malinin AI, Oshrine BR, Lowry DR, Sane DC, Tanguay JF, Steinhubl SR, Berger PB, O'Connor CM, Hennekens CH. Absence of interaction between atorvastatin or other statins and clopidogrel - Results from the interaction study. Arch Intern Med (2004); 164: 2051.
- Shepherd J, Hunninghake DB, Stein EA, Kastelein JJP, Harris S, Pears J, Hutchinson HG. Safety of rosuvastatin. Am J Cardiol (2004); 94: 882.
- Stewart WC, Stewart JA, Day DG, Sharpe ED, Jenkins JN. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy. Eye (2004); 18: 990.
- Wei L, Flynn R, Murray GD, MacDonald TM. Use and adherence to β-blockers for secondary prevention of myocardial infarction: Who is not getting the treatment?. Pharmacoepidemiol Drug Saf (2004); 13: 761.
- 5. CNS Depressive Agents
- Abraham G, Owen J. Topiramate can cause lithium toxicity (Letter). J Clin Psychopharmacol (2004); 24: 565.
- Adam S, Van Bommel J, Pelka M, Dirckx M, Jonsson D, Klein J. Propofol-induced injection pain: Comparison of a modified propofol emulsion to standard propofol with premixed lidocaine. Anaesth Analg (2004); 99: 1076.
- Allam JP, Paus T, Reichel C, Bieber T, Novak N. DRESS syndrome associated with carbamazepine and phenytoin. Eur J Dermatol (2004); 14: 339.
- Armstrong C, Burak KW, Beck PL. Benzocaine-induced methemoglobinemia: A condition of which all endoscopists should be aware. Can J Gastroenterol (2004); 18: 625.
- Ault MJ. Catheter occlusion from intravenous phenytoin (Letter). Ann Emerg Med (2004); 44: 428.
- Bavdekar SB, Muranjan MN, Gogtay NJ, Kantharia V, Kshirsagar NA. Anticonvulsant hypersensitivity syndrome: Lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment (Case Report). Ann Pharmacother (2004); 38: 1648.
- Choi YF, Wong TW, Lau CC. Midazolam is more likely to cause hypotension than etomidate in emergency department rapid sequence intubation. Emerg Med J (2004); 21: 700.
- Cladis F, Litman R. Cardiac toxicity from 3% 2-chlorprocaine (Reply). Anesthesiology (2004); 101: 1036.
- Davern TJ. Acetaminophen hepatotoxicity (Letter). Hepatology (2004); 40: 1021.
- De Jong RH. Troubling incidence of lidocaine radiculotoxicity (TNS) in volunteers (Letter). Anaesth Analg (2004); 99: 1265.
10.1213/00000539-200410000-00066 Google Scholar
- De Jong RH. Overnight stay lowers incidence of lidocaine radiculotoxicity (“TNS“) (Letter). Anaesth Analg (2004); 99: 1270.
- Ecevit CG, Aydogan A, Kavakli T, Altinoz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol (2004); 31: 279.
- Fischer M, Hamm H, Wirbelauer J. Severe drug-related skin reaction: Toxic epidermal necrolysis caused by carbamazepine (German, English Abstract). Klin Padiatr (2004); 216: 288.
- Galson S. Acetaminophen hepatotoxicity (Reply). Hepatology (2004); 40: 1022.
- Johnson BA, Ait-Daoud N, Aubin HJ, Van den Brink W, Guzzetta R, Loewy J, Silverman B, Ehrich E. A pilot evaluation of the safety and tolerability of repeat dose administration of long-acting injectable naltrexone (Vivitrex®( in patients with alcohol dependence. Alcohol Clin Exp Res (YR); 28: 1356.
- Kouri ME, Kopacz DJ. Troubling incidence of lidocaine radiculotoxicity (TNS) in volunteers (Response). Anaesth Analg (2004); 99: 1265.
10.1213/00000539-200410000-00066 Google Scholar
- Lee A, Chui PT, Aun CST, Gin T, Lau ASC. Possible interaction between sevoflurane and Aloe vera (Case Report). Ann Pharmacother (2004); 38: 1651.
- Mallet L, Babin S, Morais JA. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman (Case Report). Ann Pharmacother (2004); 38: 1643.
- McCall M, Bourgeois JA. Valproic acid-induced hyperammonemia - A case report. J Clin Psychopharmacol (2004); 24: 521.
- Missant C, Teunkens A, Vandermeersch E, Van de Velde M. Intrathecal clonidine prolongs labour analgesia but worsens fetal outcome: A pilot study. Can J Anaesth (2004); 51: 696.
- Mongin G, Yakusevich V, Kope A, Shostak N, Pikhlak E, Popdan L, Simon J, Navarro C, Fortier L, Robertson S, Bouchard S. Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol - A randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee. Clin Drug Invest (2004); 24: 545.
- Nava-Ocampo AA, Alarcon-Almanza JM, Moyao-Garcia D, Ramirez-Mora JC, Salmeron J. Halothane, isoflurane and sevoflurane in pediatric anesthesia: Can we decrease costs without increasing adverse events? (Letter). Pediatr Anaesth (2004); 14: 891.
- Rasmussen M. Carbamazepine and myasthenia gravis (Letter). Neuropediatrics (2004); 35: 259.
- Saricaoglu F, Dal D. Cardiac arrest in a patient with Larsen syndrome under sevoflurane anesthesia (Letter). Pediatr Anaesth (2004); 14: 889.
- Sarkar C, Das B, Baral P. Analgesic use in dentistry in a tertiary hospital in western Nepal. Pharmacoepidemiol Drug Saf (2004); 13: 729.
- Shroff PK, Mayhew JF. Cardiac toxicity from 3% 2-chlorprocaine (Letter). Anesthesiology (2004); 101: 1036.
- Silverman ME, Shih RD, Allegra J. Morphine induces less nausea than meperidine when administered parenterally. J Emerg Med (2004); 27: 241.
- Tarkkila P. Overnight stay lowers incidence of lidocaine radiculotoxicity (“TNS”) (Response). Anaesth Analg (2004); 99: 1271.
10.1213/00000539-200410000-00081 Google Scholar
- Van de Velde M. Does intrathecal sufentanil really cause episodes of fetal bradycardia? (Response). Anaesth Analg (2004); 99: 1267.
10.1213/00000539-200410000-00071 Google Scholar
- Van Rooij LGM, Toet MC, Rademaker KMA, Groenendaal F, De Vries LS. Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment. Eur J Pediatr (2004); 163: 637.
- Waxler B, Mondragon SA, Patel SN, Nedumgottil K. Prophylactic ondansetron does not reduce the incidence of itching induced by intrathecal sufentanil. Can J Anaesth (2004); 51: 685.
- Weaver DF. “Organic” pseudoseizures as an unrecognized side-effect of anticonvulsant therapy. Seizure (2004); 13: 467.
- 6. Non-steroidal Anti-inflammatory Agents
- Body R, Potier K. Non-steroidal anti-inflammatory drugs and exacerbations of asthma in children. Emerg Med J (2004); 21: 713.
- Carvajal A, Arias LHM, Vega E, Sanchez JAG, Rodriguez IM, Ortega PG, Del Pozo JG. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study. Eur J Clin Pharmacol (2004); 60: 439.
- Dieppe PA, Ebrahim S, Martin RM, Juni P. Lessons from the withdrawal of rofecoxib - Patients would be safer if drug companies disclosed adverse events before licensing (Editorial). Br Med J (2004); 329: 867.
- Dominick KL, Bosworth HB, Jeffreys AS, Grambow SC, Oddone EZ, Horner RD. Racial/ethnic variations in non-steroidal anti-inflammatory drug (NSAID) use among patients with osteoarthritis. Pharmacoepidemiol Drug Saf (2004); 13: 683.
- FitzGerald GA. Coxibs and cardiovascular disease. N Engl J Med (2004); 351: 1709.
- Galindo EC, Bujan JJG, Silva JMG, Martinez W, Hernando MV, Fonseca E. Fixed drug eruption from piroxicam (Case Report). J Eur Acad Dermatol Venereol (2004); 18: 586.
- Goldberg D, Panigrahi D, Barazi M, Abelson M, Butrus S. A case of rofecoxib-associated Stevens-Johnson syndrome with corneal and conjunctival changes. Cornea (2004); 23: 736.
- Hawkey CC, Svoboda P, Fiedorowicz-Fabrycy IF, Nasonov EL, Pikhlak EG, Cousin M, Gitton X, Hoexter G. Gastroduodenal safety and tolerability of lumiracoxib compared with ibuprofen and celecoxib in patients with osteoarthritis. J Rheumatol (2004); 31: 1804.
- Jacobus S, Schneeweiss S, Chan KA. Exposure misclassification as a result of free sample drug utilization in automated claims databases and its effect on a pharmacoepidemiology study of selective COX-2 inhibitors. Pharmacoepidemiol Drug Saf (2004); 13: 695.
- Kammerl MC, Debler J, Riegger GA, Kramer BK. COX-2 inhibitors and risk of heart failure (Letter). Lancet (2004); 364: 1486.
- Kanik EA, Canbaz H, Colak T, Aydin S. Chemopreventive effect of nonsteroidal anti-inflammatory drugs on the development of a new colorectal polyp or adenoma in a high-risk population: A meta-analysis. Curr Ther Res (2004); 65: 345.
- Kaushik P, Zuckerman SJ, Campo NJ, Banda VR, Hayes SD, Kaushik R. Celecoxib-induced methemoglobinemia (Case Report). Ann Pharmacother (2004); 38: 1635.
- Lee C, Straus WL, Balshaw R, Barlas S, Vogel S, Schnitzer TJ. A comparison of the efficacy and safety nonsteroidal antiinflammatory agents acetaminophen in the treatment of osteoarthritis: A meta-analysis. Arthritis Rheum (2004); 51: 746.
- Mamdani M, Juurlink D, Laupacis A. COX-2 inhibitors and risk of heart failure (Reply). Lancet (2004); 364: 1487.
- Peura DA. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med (2004); 117: 63S.
- Rodondi N, Bauer DC. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events (Editorial). Am J Med (2004); 117: 528.
- Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee - A randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med (2004); 164: 2017.
- Roth SH. Nabumetone - Therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis. Drugs (2004); 64: 2344.
- Sweet BV, Townsend KA, Tsai CY. Risk assessment of NSAID-induced gastrointestinal toxicity in ambulatory care patients. Am J Health Syst Pharm (2004); 61: 1917.
- Van Oijen MGH, Laheij RJF, Peters WHM, Jansen JBMJ, Verheugt FWA. Association of aspirin use with vitamin B12 deficiency (Results of the BACH Study). Am J Cardiol (2004); 94: 975.
- Wardle EN. COX-2 inhibitors and risk of heart failure (Reply). Lancet (2004); 364: 1487.
- 7. CNS Agents
- Alevizos B, Papageorgiou C, Christodoulou GN. Obsessive-compulsive symptoms with olanzapine (Letter). Int J Neuropsychopharmacol (2004); 7: 375.
- Alevizos B, Lykouras L, Zervas IM, Christodoulou GN. “Risperidone-induced obsessive-compulsive symptoms: Serotonin-dopamine imbalance?” (Reply). J Clin Psychopharmacol (2004); 24: 549.
- Anghelescu I, Wolf J. Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: A case report (Letter). J Clin Psychiatry (2004); 65: 1286.
- Bahl S, Cotterchio M, Kreiger N, Klar N. Antidepressant medication use and non-Hodgkin's lymphoma risk: No association. Am J Epidemiol (2004); 160: 566.
- Barbui C, Ciuna A, Nose M, Levi D, Patten SB, Amaddeo F, Tansella M. The changing pattern of inpatient antipsychotic drug use in Italy (Letter). J Clin Psychopharmacol (2004); 24: 559.
- Bartlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, Du Berger R. Longitudinal patterns of new benzodiazepine use in the elderly. Pharmacoepidemiol Drug Saf (2004); 13: 669.
- Bolling MY, Kohlenberg RJ. Reasons for quitting serotonin reuptake inhibitor therapy: Paradoxical psychological side effects and patient satisfaction. Psychother Psychosom (2004); 73: 380.
- Bucur M, Mahmood T. Olanzapine-induced clitoral priapism (Letter). J Clin Psychopharmacol (2004); 24: 572.
- Byerly MJ, Lescouflair E, Weber MT, Bugno RM, Fisher R, Carmody T, Varghese F, Rush AJ. An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction. J Sex Marital Ther (2004); 30: 325.
- Cohen JS. Antidepressants: An avoidable and solvable controversy. Ann Pharmacother (2004); 38: 1743.
- De Vriest TW, De Jong-van de Berg LTW, Hadders-Algra M. Paroxetine during lactation: Is it really safe for the infant? (Letter). Acta Paediatr (2004); 93: 1406.
- Dew RE, Hughes D. Acute dystonic reaction with moderate-dose ziprasidone (Letter). J Clin Psychopharmacol (2004); 24: 563.
- Esposito D, Aouille J, Rouillon F, Limosin F. Two-year follow-up of a patient with successful continuation of clozapine treament despite morning pseudoneutropenia (Letter). J Clin Psychiatry (2004); 65: 1281.
- Finley PR. Antidepressants, suicide, and the FDA: A loose association. Ann Pharmacother (2004); 38: 1739.
- Greist J, McNamara RK, Mallinckrodt CH, Rayamajhi JN, Raskin J. Incidence and duration of antidepressant-induced nausea: Duloxetine compared with paroxetine and fluoxetine. Clin Ther (2004); 26: 1446.
- Hartter S, Connemann B, Schonfeldt-Lecuona C, Sachse J, Hiemke C. Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole (Letter). J Clin Psychopharmacol (2004); 24: 568.
- Hasselstrom J, Linnet K. Quetiapine serum concentrations in psychiatric patients - The influence of comedication. Ther Drug Monit (2004); 26: 486.
- Henderson TA. Mania induction associated with atomoxetine (Letter). J Clin Psychopharmacol (2004); 24: 567.
- Hirose T, Uwahodo Y, Yamada S, Miwa T, Kikuchi T, Kitagawa H, Burris KD, Altar CA, Nabeshima T. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile. J Psychopharmacol (2004); 18: 375.
- Howes OD, Rifkin L. Diabetic keto-acidotic (DKA) coma following olanzapine initiation in a previously euglycaemic woman and successful continued therapy with olanzapine (Case Report). J Psychopharmacol (2004); 18: 435.
- Jackson S, Ham RJ, Wilkinson D. The safety and tolerability of donepezil in patients with Alzheimer's disease. Br J Clin Pharmacol (2004); 58: 1.
- Jhirwal OP, Parsad D, Basu D. Skin hyperpigmentation induced by olanzapine, a novel antipsychotic agent (Letter). Int J Dermatol (2004); 43: 778.
- Kao CL, Huang SC, Yang YJ, Tsai SJ. A case of parenteral zolpidem dependence with opioid-like withdrawal symptoms (Letter). J Clin Psychiatry (2004); 65: 1287.
- Kawaguchi A, Ohmori M, Tsuruoka S, Nishiki K, Harada K, Miyamori I, Yano R, Nakamura T, Masada M, Fujimura A. Drug interaction between St John's wort and quazepam. Br J Clin Pharmacol (2004); 58: 403.
- Kooij JJS, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychol Med (2004); 34: 973.
- Kopf D, Westphal S, Luley CW, Ritter S, Gilles M, Weber-Hamann B, Lederbogen F, Lehnert H, Henn FA, Heuser I, Deuschle M. Lipid metabolism and insulin resistance in depressed patients - Significance of weight, hypercortisolism, and antidepressant treatment. J Clin Psychopharmacol (2004); 24: 527.
- Koves IH, Jarman FC, Cameron FJ. Antipsychotic medication and marked hyperprolactinaemia: Iatros or true prolactinoma?. Acta Paediatr (2004); 93: 1543.
- Le Melledo JM, Abadia MDC, Newman S, Bailey D, Tsuyuki R, Gyenes G. The effects of newer antidepressants on low-density lipoprotein cholesterol levels (Letter). J Clin Psychiatry (2004); 65: 1017.
- Leal A, Rosillon D, Mehnert A, Jarema M, Remington G. Healthcare resource utilization during 1-year treatment with long-acting, injectable risperidone. Pharmacoepidemiol Drug Saf (2004); 13: 811.
- Lee A, Giesbrecht E, Dunn E, Ito S. Excretion of quetiapine in breast milk (Letter). Am J Psychiatry (2004); 161: 1715.
- Leslie DL, Rosenheck RA. Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications. Am J Psychiatry (2004); 161: 1709.
- Meenagh C, Mulholland C, Ryan MF. Magnesium homeostasis antipsychotic-induced QTc prolongation (Letter). J Psychopharmacol (2004); 18: 438.
- Monji A, Yanagimoto K, Yoshida I, Hashioka S. SSRI-induced enuresis - A case report (Letter). J Clin Psychopharmacol (2004); 24: 564.
- Nagy CF, Kumar D, Cullen EI, Bolton WK, Marbury TC, Gutierrez MJ, Hutman HW, Pratt RD. Steady-state pharmacokinetics and safety of donepezil HCl in subjects with moderately impaired renal function. Br J Clin Pharmacol (2004); 58: 18.
- Nagy CF, Kumar D, Perdomo CA, Wason S, Cullen EI, Pratt RD. Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: Assessment of pharmacokinetic changes and safety following single and multiple oral doses. Br J Clin Pharmacol (2004); 58: 25.
- Nicholas LM, Ford AL, Esposito SM, Ekstrom RD, Golden RN. The effects of newer antidepressants on low-density lipoprotein cholesterol levels (Reply). J Clin Psychiatry (2004); 65: 1018.
- Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: Assessment of pharmacokinetic changes and safety following multiple oral doses. Br J Clin Pharmacol (2004); 58: 41.
- Ravic M, Warrington S, Boyce M, Dunn K, Johnston A. Repeated dosing with donepezil does not affect the safety, tolerability or pharmacokinetics of single-dose thioridazine in young volunteers. Br J Clin Pharmacol (2004); 58: 34.
- Ravindran A, Siverstone P, Lacroix D, Van Schaick E, Vermeulen A, Alexander J. Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder. Clin Pharmacokinet (2004); 43: 733.
- Reyes JF, Vargas R, Kumar D, Cullen EI, Perdomo CA, Pratt RD. Steady-state pharmacokinetics, pharmacodynamics and tolerability of donepezil hydrochloride in hepatically impaired patients. Br J Clin Pharmacol (2004); 58: 9.
- Reyes JF, Preskorn SH, Khan A, Kumar D, Cullen EI, Perdomo CA, Pratt RD. Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: Assessment of pharmacokinetic changes and safety following multiple oral doses. Br J Clin Pharmacol (2004); 58: 50.
- Schwartz TL, Jindal S, Simionescu M, Nihalani N, Azhar N, Tirmazi S, Hussein J. Effectiveness of orlistat versus diet and exercise for weight gain associated with antidepressant use - A pilot study (Letter). J Clin Psychopharmacol (2004); 24: 555.
- Sevincok L, Topaloglu B, Kiyilioglu N. Neurologic soft signs and olanzapine treatment in chronic schizophrenia (Letter). J Clin Psychopharmacol (2004); 24: 571.
- Tomaselli G, Modestin J. Repetition of serotonin syndrome after reexposure to SSRI - A case report (Letter). Pharmacopsychiatry (2004); 37: 236.
- Van Elst LT, Baumer D, Ebert D, Trimble MR. Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia. Pharmacopsychiatry (2004); 37: 217.
- Webber MA, Mahmud W, Lightfoot JD, Shekhar A. Rhabdomyolysis and compartment syndrome with coadministration of risperidone and simvastatin (Case Report). J Psychopharmacol (2004); 18: 432.
- 8. Anti-neoplastic Agents
- Babaoglu MO, Karadag O, Saikawa Y, Altundag K, Elkiran T, Yasar U, Bozkurt A. Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: A case report. Eur J Clin Pharmacol (2004); 60: 455.
- Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O. Platinum compound-related ototoxicity in children - Long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol (2004); 26: 649.
- Boccia R, Anne PR, Bourhis J, Brizel D, Daly C, Holloway N, Hymes S, Koukourakis M, Kozloff M, Turner M, Wasserman T. Assessment and management of cutaneous reactions with amifostine administration: Findings of the Ethyol (amifostine) Cutaneous Treatment Advisory Panel (ECTAP). Int J Radiat Oncol Biol Phys (2004); 60: 302.
- Carrera C, Cibeira MT, Iranzo P, Esteve J, Nomdedeu B, Herrero C. Dermatomyositis associated with acute myeloid leukaemia: A paraneoplastic association or a drug-induced phenomenon?. Acta Derm Venereol (2004); 84: 401.
- Cavaletti G, Bogliun G, Marzorati L, Zincone A, Piatti M, Colombo N, Franchi D, La Presa MT, Lissoni A, Buda A, Fei F, Cundari S, Zanna C. Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy. Ann Oncol (2004); 15: 1439.
- De Savary N, Lee R, Vaidya B. Severe hypothyroidism after thalidomide treatment (Case Report). J R Soc Med (2004); 97: 443.
- Dumouchel-Champagne H, Ferry T, Bouhour D, Granier P. Allopurinal-induced aseptic meningitis (Letter) (French). Presse Med (2004); 33: 1008.
- Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol (2004); 22: 3485.
- Fujisaki G, Inokuchi C, Murashige N. Doxorubicin-induced myocardial injury (Letter). N Engl J Med (2004); 351: 1908.
- Garrett WV, Brown JRI, Pickering D, Andrews SM. Critical limb ischaemia associated with chemotherapy for breast cancer (Case Report). J R Soc Med (2004); 97: 444.
- Georgieva J, Steinhoff M, Orfanos CE, Treudler R. Ethylene-oxide-induced pruritus associated with extracorporeal photochemotherapy (Letter). Transfusion (2004); 44: 1532.
- Glaus A, Knipping C, Morant R, Bohme C, Lebert B, Beldermann F, Glawogger B, Ortega P, Husler A, Deuson R. Chemotherapy-induced nausea and vomiting in routine practice: A European perspective. Support Care Cancer (2004); 12: 708.
- Hachisuga T, Saito T, Kigawa J, Ohwada M, Yamazawa K, Yasue A, Iwasaka T, Sugiyama T, Kita T, Nagai N. Clinicopathologic study of 56 patients with endometrial cancer during or after adjuvant tamoxifen use for their breast cancers. Gynecol Oncol (2004); 95: 139.
- Karadag O, Babaoglu MO, Altundag K, Elkiran T, Yasar U, Bozkurt A. 5-Fluorouracil-induced coronary spasm: May inhibition of hyperpolarization factors produced by CYP2C enzymes be the cause? (Letter). Oncology-Basel (2004); 66: 510.
- Larson FO, Hansen SW. Severe neurotoxicity caused by gemcitabine treatment (Case Report). Acta Oncol (2004); 43: 590.
- Lau PM, Stewart K, Dooley M. The ten most common adverse drug reactions (ADRs) in oncology patients: Do they matter to you?. Support Care Cancer (2004); 12: 626.
- Lipshultz SE, Silverman LB, Sallan SE. Doxorubicin-induced myocardial injury (Reply). N Engl J Med (2004); 351: 1908.
- Marks R, Owens M, Walters SA. Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas (Letter). Arch Dermatol (2004); 140: 1284.
- Menzin J, Lang K, Earle CC, Glendenning A. Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia - A population-based analysis. Drugs Aging (2004); 21: 737.
- Mohammadianpanah M, Omidvari S, Mosalaei A, Ahmadloo N. Cisplatin-induced hypokalemic paralysis (Case Report). Clin Ther (2004); 26: 1320.
- Morgan M, Bowers DC, Gruchalla RS, Khan DA. Safety and efficacy of repeated monthly carboplatin desensitization (Letter). J Allergy Clin Immunol (2004); 114: 974.
- Munstedt K, Borces D, Bohlmann MK, Zygmunt M, Von Georgi R. Glucocorticoid administration in antiemetic therapy - Is it safe?. Cancer (2004); 101: 1696.
- Oberholzer K, Kunz RP, Dittrich M, Thelen M. Anthracycline-induced cardiotoxicity: Cardiac MRI after treatment for childhood cancer. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb (2004); 176: 1246.
- Phelan JT, Broder J, Kouides PA. Near-fatal uterine hemorrhage during induction chemotherapy for acute myeloid leukemia: A case report of bilateral uterine artery embolization. Am J Hematol (2004); 77: 151.
- Pitini V, Bramanti P, Arrigo C, Sessa E, La Gattuta G, Amata C. Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient (Letter). Ann Oncol (2004); 15: 1446.
- Rossini MS, De Souza EM, Cintra ML, Pagnano KB, Chiari AC, Lorand-Metzet I. Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia. J Eur Acad Dermatol Venereol (2004); 18: 538.
- Ruiz I, Del Valle J, Gomez A. Gemcitabine and haemolytic-uraemic syndrome (Letter). Ann Oncol (2004); 15: 1575.
- Saif MW, Wood JE, McGee PJ, Diasio RB. Peripheral neuropathy associated with capecitabine (Case Report). Anticancer Drugs (2004); 15: 767.
- Seshadri T, Seymour JF, McArthur GA. Oligospermia in a patient receiving imatinib therapy for the hypereosinophilic syndrome (Letter). N Engl J Med (2004); 351: 2134.
- Siegelmann-Danieli N, Bardo M, Law A, Fisk D, Bernath A. Interstitial pneumonitis in a patient with melanoma treated with the high dose interferon α 2b regimen. Isr Med Assoc J (2004); 6: 636.
- Thomas C, Cans C, Pelletier R, De Robertis C, Hazzouri M, Sele B, Rousseaux S, Hennebicq S. No long-term increase in sperm aneuploidy rates after anticancer therapy: Sperm fluorescence in situ hybridization analysis in 26 patients treated for testicular cancer or lymphoma. Clin Cancer Res (2004); 10: 6535.
- Tiersten A, Wo J, Jacobson C, Weitzman A, Horwich T, Hesdorffer C, Savage D, Troxel A. Cardiac toxicity observed in association with high-dose cyclophosphamide-based chemotherapy for metastatic breast cancer. Breast (2004); 13: 341.
- Tominaga K, Higuchi K, Okazaki H, Suto R, Hamaguchi M, Tanigawa T, Sasaki E, Shiba M, Watanabe T, Fujiwara Y, Oshitani N, Matsumoto T, Arakawa T. Safety and efficacy of S-1, a novel oral fluorouracil antitumor drug, for a chronic renal failure patient maintained on hemodialysis. Oncology (2004); 66: 358.
- Wong SF, Jakowatz JG, Taheri R. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma (Case Report). Ann Pharmacother (2004); 38: 1655.
- Zalewska-Szewczyk B, Andrzejewski W, Bodalski E. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2004); 43: 600.
- 9. Haematological Agents
- Abdel-Razeq HN, Bajouda AA, Khalil MM, Ashmeg AK. Treating heparin-induced thrombocytopenia - The unconventional way!. Saudi Med J (2004); 25: 1258.
- Arsan S, Ak K, Isbir SC. Clopidogrel in coronary artery surgery (Letter). Eur J Cardiothorac Surg (2004); 26: 869.
- Badaoui R, Chebboubi K, Delmas J, Jakobina S, Mahjoub Y, Riboulot M. Splenic rupture and anticoagulant therapy (Case Report) (French). Ann Fr Anesth Reanim (2004); 23: 748.
- Bulang T, Schonlebe J, Haroske G, Porst H. Acute liver failure caused by phenprocoumon - Three case reports (German, English Abstract). Z Gastroenterol (2004); 42: 1055.
- Cheng TO. Potential interaction between soy milk and warfarin (Letter). Am Fam Physician (2004); 70: 1231.
- Gaiser RR, Berkowitz DH, Chou D. Epidural blood patch in a patient taking enoxaparin. J Clin Anesth (2004); 16: 386.
- Hefer D, Jaloudi M. Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: A case report and discussion of the relevant literature. Ann Hematol (2004); 83: 661.
- Kagansky N, Knobler H, Rimon E, Ozer Z, Levy S. Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med (2004); 164: 2044.
- La Shell MS, Tankersley MS. Heparin hypersensitivity: A case of mistaken identity (Letter). Ann Allergy Asthma Immunol (2004); 93: 304.
- Levy JH. Safety of aprotinin in heparinized and nonheparinized patients. J Cardiothorac Vasc Anesth (2004); 18: 38S.
- Luu H, Ewenstein B. FEIBA® safety profile in multiple modes of clinical and home-therapy application. Haemophilia (2004); 10: 10.
- Mikou MM, Mouaffak Y, Benyacob A, Mossadek A, Faroudy M, Ababou A, Lazreq C, Sbihi A. Haemocholecyst: A rare complication of anticoagulant treatment (Case Report) (French). Ann Fr Anesth Reanim (2004); 23: 733.
- Moll S, Huffman J. Cholesterol emboli associated with warfarin treatment. Am J Hematol (2004); 77: 194.
- Okada H, Kikuta T, Watanabe Y, Kanno Y, Sugahara S, Suzuki H. Ticlopidine induces lupus in a haemodialysis patient (Letter). Nephrol Dial Transplant (2004); 19: 2685.
- Rice L. Heparin-induced thrombocytopenia - Myths and misconceptions (that will cause trouble for you and your patient) (Commentary). Arch Intern Med (2004); 164: 1961.
- Wester JPJ, Haas FJLM, Biesma DH, Leusink JA, Veth G. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients. Intensive Care Med (2004); 30: 1927.
- 10. Neuroregulator-Blocking Agents
- Barton JC. Angioedema associated with imiquimod (Letter). J Am Acad Dermatol (2004); 51: 477.
- Caeiro L, Ferro JM, Claro MI, Coelho J, Albuquerque R, Figueira ML. Delirium in acute stroke: A preliminary study of the role of anticholinergic medications. Eur J Neurol (2004); 11: 699.
- Hanlon JT, Landerman LR, Artz MB, Gray SL, Fillenbaum GG, Schmader KE. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. Pharmacoepidemiol Drug Saf (2004); 13: 781.
- Pak F. Green urine: An association with metoclopramide (Letter). Nephrol Dial Transplant (2004); 19: 2677.
- 12. Immunosuppressive Agents
- Aringer M, Graninger WB, Steiner GN, Smolen JS. Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus - An open-label study. Arthritis Rheum (2004); 50: 3161.
- Feuillet L, Guedj E, Laksiri N, Philip E, Habib G, Pelletier J, Cherif AA. Deep vein thrombosis after intravenous immunoglobulins associated with methylprednisolone (Case Report). Thromb Haemost (2004); 92: 662.
- Hartmann SN, Rordorf CM, Milosavljev S, Branson JM, Chales GH, Juvin RR, Lafforgue P, Le Parc JM, Tavernier CG, Meyer OC. Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients. Ann Pharmacother (2004); 38: 1582.
- Heifets M, Saeed MI, Parikh MH, Sierka D, Kumar MSA. Induction immunosuppression in kidney transplant recipients older than 60 years of age - Safety and efficacy of ATGAM®, OKT3® and Simulect®. Drugs Aging (2004); 21: 747.
- Iikuni N, Iwami S, Kasai S, Tokuda H. Noncardiogenic pulmonary edema in low-dose oral methotrexate therapy. Intern Med (2004); 43: 846.
- Johansson B. Visual dysfunction and methotrexate (Letter). Acta Ophthalmol Scand (2004); 82: 627.
- Kahan BD, Stepkowski S, Kilic M, Katz SM, Van Buren CT, Welsh MS, Tami JA, Shanahan WR. Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft rejection. Transplantation (2004); 78: 858.
- Marino IR, Doria C, Scott VL, Foglieni CS, Lauro A, Piazza T, Cintorino D, Gruttadauria S. Efficacy and safety of basiliximab with a tacrolimus-based regimen in liver transplant recipients. Transplantation (2004); 78: 886.
- Mitsias PD, Lu M, Morris D, Silver B, Lewandowski C, Papamitsakis NI, Khaligi MM, Ebadian HB, Zhao QM, Soltanian-Zadeh H, Daley S, Hearshen D, Ewing JR, Patel SC, Chopp M. Treatment of acute supratentorial ischemic stroke with abciximab is safe and may result in early neurological improvement - A preliminary report. Cerebrovasc Dis (2004); 18: 249.
- Mori H, Yamanaka K, Kaketa M, Tamada K, Hakamada A, Isoda K, Yamanishi K, Mizutani H. Drug eruption caused by azathioprine: Value of using the drug-induced lymphocytes stimulation test for diagnosis. J Dermatol (2004); 31: 731.
- Neff GW, Ruiz P, Madariaga JR, Nishicla S, Montalbano M, Meyer D, Levi DM, Tzakis AG, O'Brien CB. Sirolimus-associated hepatotoxicity in liver transplantation. Ann Pharmacother (2004); 38: 1593.
- Rejon E, Gimenez MD, Mayordomo L, Rodriguez S, Gonzalez MP, Marenco JL. Therapeutic efficacy and safety of multiple intravenous infusions of infliximab in refractory ankylosing spondylitis patients with axial involvement. Scand J Rheumatol (2004); 33: 323.
- Shefet D, Ben-Dor I, Lustig S. Sirolimus-induced interstitial pneumonitis after renal transplantation (Letter). Transplantation (2004); 78: 950.
- 13. Autonomic Agents
- Briani C, Cagnin A, Chierichetti F, Tiberio M, Battistin L, Pizzolato G. Thiethylperazine-induced parkinsonism: In vivo demonstration of dopamine D2 receptors blockade (Case Report). Eur J Neurol (2004); 11: 709.
- Debruyne F, Barkin J, Van Erps P, Reis M, Tammela TLJ, Roehrborn C. Efficacy and safety of long-term treatment with the dual 5α-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol (2004); 46: 488.
- Gercek A, Baykan N, Dagcinar A, Ozek MM. Does general anesthesia potentiate the GABA-ergic action of intrathecal baclofen? (Letter). J Neurosurg Anesthesiol (2004); 16: 323.
- Muller T, Hefter H, Hueber R, Jost WH, Leenders KL, Odin P, Schwarz J. Is levodopa toxic?. J Neurol (2004); 251: 44.
- Schwartz DC, Smith DJ. Colonic ischemia associated with naratriptan use. J Clin Gastroenterol (2004); 38: 790.
- Zijlmans JCM, Debilly B, Rascol O, Lees AJ, Durif F. Safety of entacapone and apomorphine co administration in levodopa-treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study. Mov Disord (YR); 19: 1006.
- 14. Respiratory System Agents
- Kaae R, Agertoft L, Pedersen S, Nordvall SL, Pedroletti C, Bengtsson T, Johannes-Hellberg I, Rosenborg J. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline. Br J Clin Pharmacol (2004); 58: 411.
- Loewen AHS, Hudon ME, Hill MD. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray. Can Med Assoc J (2004); 171: 593.
- Mahler DA, Huang S, Tabrizi M, Bell GM. Efficacy and safety of a monoclonal antibody recognizing interleukin-8 in COPD - A pilot study. Chest (2004); 126: 926.
- Marguet C, Couderc L, Lubrano M. Adverse events of inhaled steroids in childhood (French, English Abstract). Arch Pediatr Adolesc Med (2004); 11: 113S.
- Van Staa TP, Bishop N, Leufkens HGM, Cooper C. Are inhaled corticosteroids associated with an increased risk of fracture in children?. Osteoporos Int (2004); 15: 785.
- Visser MJ, Van der Veer E, Postma DS, Arends LR, De Vries TW, Brand PLP, Duiverman EJ. Side-effects of fluticasone in asthmatic children: No effects after dose reduction. Eur Resp J (2004); 24: 420.
- Weidinger S, Mempel M, Ollert M, Elser I, Rakoski J, Kohn FM, Ring J. Anaphylaxis to mizolastine (Letter). J Allergy Clin Immunol (2004); 114: 979.
- 16. Reproductive System Agents
- Bundred NJ. Breast cancer and HRT use. Maturitas (2004); 49: S3.
- Bundred NJ, Turner LE. Postmenopausal hormone therapy before and after breast cancer: Clinical experiences. Maturitas (2004); 49: S22.
- Gauthier E, Paoletti X, Clavel-Chapelon F. Breast cancer risk associated with being treated for infertility: Results from the French E3N cohort study. Hum Reprod (2004); 19: 2216.
- Gris JC, Nouvellon-Cochery E, Mares P. Increased resistance to activated protein C in women taking third-generation oral contraceptives? (Letter). Blood (2004); 104: 1907.
- Kloosterboer HJ. Tissue-selective effects of tibolone on the breast. Maturitas (2004); 49: S5.
- Li CI. Postmenopausal hormone therapy and the risk of breast cancer: The view of an epidemiologist. Maturitas (2004); 49: 44.
- Lim HJ, Lee MS, Cho YH, Kazumi U. A comparative study of knowledge about and attitudes toward the combined oral contraceptives among Korean and Japanese university students. Pharmacoepidemiol Drug Saf (2004); 13: 741.
- Liu PY, Swerdloff RS, Veldhuis JD. The rationale, efficacy and safety of androgen therapy in older men: Future research and current practice recommendations. J Clin Endocrinol Metab (2004); 89: 4789.
- Speroff L. Postmenopausal hormone therapy and the risk of breast cancer: A clinician's view. Maturitas (2004); 49: 51.
- Von Schoultz B. The effects of tibolone and oestrogen-based HT on breast cell proliferation and mammographic density. Maturitas (2004); 49: S16.
- 17. Gastrointestinal System Agents
- Chebli JMF, Gaburri PD, De Souza AFM, Da Silva CEAP, Pinto JRF, Felga GEG. Benign intracranial hypertension during corticosteroid therapy for idiopathic ulcerative colitis: Another indication for cyclosporine? (Letter). J Clin Gastroenterol (2004); 38: 827.
- Ecker RD, Wijdicks EFM, Wix K, McClelland R. Does famotidine induce thrombocytopenia in neurosurgical patients?. J Neurosurg Anesthesiol (2004); 16: 291.
- Felley C, Michetti P. Safety of infliximab in patients suffering from inflammatory bowel disease (Editorial). Digestion (2004); 70: 1.
- Goettsch WG, Van den Boom G, Breekveldt-Postma NS, Smout AJPM, Herings RMC. Treatment patterns and health care costs of mebeverine-treated IBS patients: A case-control study. Pharmacoepidemiol Drug Saf (2004); 13: 803.
- Guthmann RA. Clinical commentary - No evidence of long-term adverse health effects from PPIs, but cost still a problem. J Fam Pract (2004); 53: 742.
- Kollmeier AP, Eddleston J, Zuraw BL, Christiansen SC. Recurrent anaphylaxis linked to pantoprazole (Letter). J Allergy Clin Immunol (2004); 114: 975.
- Laheij RJF, Sturkenboom MCJM, Hassing RJ, Dieleman J, Stricker BHC, Jansen JBMJ. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA (2004); 292: 1955.
- Lembo A. Irritable bowel syndrome medications side effects survey. J Clin Gastroenterol (2004); 38: 776.
- Malaty W, Stigleman S, Mayer J. Is the long-term use of proton pump inhibitors safe?. J Fam Pract (2004); 53: 740.
- Moore L, Sayer JA, Nayar A, Ahmed S, Tapson JS. Pantoprazole-induced acute interstitial nephritis (Case Reports). J Nephrol (2004); 17: 580.
- Seiderer J, Goke B, Ochsenkuhn T. Safety aspects of infliximab in inflammatory bowel disease patients - A retrospective cohort study in 100 patients of a German University Hospital. Digestion (2004); 70: 3.
- Van Zyl J, Van Rensburg C, Vieweg W, Fischer R. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease. Digestion (2004); 70: 61.
- 19. Teratogens/fetal exposure
- Basso M, Ghio M, Filaci G, Setti M, Indiveri F. A case of successful pregnancy in a woman with systemic sclerosis treated with cyclosporin. Rheumatology (2004); 43: 1310.
- Berkane N, Carlier P, Verstraete L, Mathieu E, Heim N, Uzan S. Fetal toxicity of valsartan and possible reversible adverse side effects. Birth Defects Res Part A Clin Mol Teratol (2004); 70: 547.
- Cimaz R, Brucato A, Meregalli E, Muscara M, Sergi P. Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: Comment on the article by Costedoat-Chalumeau et al (Letter). Arthritis Rheum (2004); 50: 3056.
- Costedoat-Chalumeau N, Amoura Z, Sebbough D, Piette JC. Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: Comment on the article by Costedoat-Chalumeau et al (Reply). Arthritis Rheum (2004); 50: 3057.
- Damase-Michel C, Vie C, Lacroix I, Lapeyre-Mestre M, Montastruc JL. Drug counselling in pregnancy: An opinion survey of French community pharmacists. Pharmacoepidemiol Drug Saf (2004); 13: 711.
- De Santis M, Carducci B, De Santis L, Lucchese A, Straface G. First case of post-conception verteporfin exposure: Pregnancy and neonatal outcome. Acta Ophthalmol Scand (2004); 82: 623.
- Doubek M, Brychtova Y, Doubek R, Janku P, Mayer J. Anagrelide therapy in pregnancy: Report of a case of essential thrombocythemia (Letter). Ann Hematol (2004); 83: 726.
- Hardy JR, Holford TR, Hall GC, Bracken MB. Strategies for identifying pregnancies in the automated medical records of the General Practice Research Database. Pharmacoepidemiol Drug Saf (2004); 13: 749.
- Hilaire ML, Cross LB, Eichner SF. Treatment of migraine headaches with sumatriptan in pregnancy. Ann Pharmacother (2004); 38: 1726.
- Howard L, Webb R, Abel K. Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis (Editorial). Br Med J (2004); 329: 933.
- Kadioglu M, Ulku C, Yaris F, Kesim M, Kalyoncu NI, Yaris E. Sibutramine use in pregnancy: Report of two cases. Birth Defects Res Part A Clin Mol Teratol (2004); 70: 545.
- Le J, Briggs GG, McKeown A, Bustillo G. Urinary tract infections during pregnancy. Ann Pharmacother (2004); 38: 1692.
- Lee JS. Does intrathecal sufentanil really cause more episodes of fetal bradycardia? (Letter). Anaesth Analg (2004); 99: 1267.
10.1213/00000539-200410000-00071 Google Scholar
- Lin AE, Peller AJ, Westpate MN, Houde K, Franz A, Holmes LB. Clonazepam use in pregnancy and the risk of malformations. Birth Defects Res Part A Clin Mol Teratol (2004); 70: 534.
- Mehta R, Golichowski A. Treatment of heparin induced thrombocytopenia and thrombosis during the first trimester of pregnancy (Letter). J Thromb Haemost (2004); 2: 1665.
- Meyohas MC, Lacombe K, Carbonne B, Morand-Joubert L, Girard PM. Enfuvirtide prescription at the end of pregnancy to a multi-treated HIV-infected woman with virological breakthrough. AIDS (2004); 18: 1966.
- Mucci LA, Lagiou P, Hsieh CC, Tamimi R, Hellerstein S, Vatten L, Adami HO, Cnattingius S, Trichopoulos D. A prospective study of pregravid oral contraceptive use in relation to fetal growth. BJOG (2004); 111: 989.
- Munns CFJ, Rauch F, Ward L, Glorieux FH. Maternal and fetal outcome after long-term pamidronate treatment before conception: A report of two cases. J Bone Miner Res (2004); 19: 1742.
- Okumus N, Turkyilmaz C, Onal EE, Atalay Y, Koc E, Nas T. Ritodrine-induced transient neutropenia in newborn twins after in utero exposure: Report of first cases (Letter). Br J Clin Pharmacol (2004); 58: 445.
- Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int J Neuropsychopharmacol (2004); 7: 329.
- 20. Others
- Amin P. Liver toxicity and pioglitazone - Data are missing (Letter). Br Med J (2004); 329: 918.
- Atalay AE, Altaykan A, Ergin G, Kutsal YG. Reversible sclerotic changes of lumbar spine and femur due to long-term oral isotretinoin therapy (Case Report). Rheumatol Int (2004); 24: 297.
- Boonen S, McClung MR, Eastell R, Fuleihan GE, Barton IP, Delmas P. Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: Implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc (2004); 52: 1832.
- Burotto M, Letelier LM. Critical appraisal: Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Rev Med Chil (2004); 132: 1011.
- Canavese C, Morra F, Morellini V, Lazzarich E, Brustia M, Bo M, Stratta P. How can we be sure that renal dysfunction after coronary angiography is just explained by contrast nephropathy? (Letter). Kidney Int (2004); 66: 1717.
- Daley MD, Norman PH, Leak JA, Nguyen DT, Bui TP, Kowalski AM, Srejic U, Popat K, Arens JF, Gershenwald JE, Hunt KK, Kuerer HM. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth (2004); 16: 332.
- Ernst E. Risks of herbal medicinal products. Pharmacoepidemiol Drug Saf (2004); 13: 767.
- Farley-Hills E. Liver toxicity and pioglitazone - Data are missing (Reply). Br Med J (2004); 329: 918.
- Jackson TL. Safety of indocyanine green as a vital stain (Letter). Anesthesiology (2004); 100: 1330.
- Krishnamurthy M, Sahouria JJ, Desai R, Caguiat J. Buformin-induced lactic acidosis - A symptom of modern healthcare malady (Letter). J Am Geriatr Soc (2004); 52: 1785.
- Mancini I, Dumon JC, Body JJ. Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: A pilot study. J Clin Oncol (2004); 22: 3587.
- Miner SES, Dzavik V, Nguyen-Ho P, Richardson R, Mitchell J, Atchison D, Seidelin P, Daly P, Ross J, McLaughlin PR, Ing D, Lewycky P, Barolet A, Schwartz L. N-Acetylcysteine reduces contrast associated nephropathy but not clinical events during long-term follow-up. Am Heart J (2004); 148: 690.
- Tonelli M, Manns B, Pannu N. How can we be sure that renal dysfunction after coronary angiography is just explained by contrast nephropathy? (Reply). Kidney Int (2004); 66: 1717.
